Practice Alert

CDC update on gonorrhea: Expand treatment to limit resistance


 

References

Regardless of the cephalosporin chosen, always administer azithromycin. If necessary, an alternative to azithromycin is doxycycline 100 mg orally twice a day. But doxycycline is not preferred because it has a multiple daily dosing requirement and higher levels of gonococcal resistance than is seen with azithromycin.

Necessary follow-up. Although routine testing for cure is not advocated for those treated with a recommended antibiotic regimen, a gonococcal culture and testing for antibiotic susceptibility should be done for any patient whose symptoms persist after treatment. Rapid tests using nucleic acid amplification are unsuitable for testing antibiotic susceptibility. The CDC does recommend retesting patients 3 months after treatment is completed because of a high prevalence of reinfection.3 If cephalosporin resistance becomes prevalent, routine tests of cure might become a recommended standard.

Report all patients with gonorrhea to the local public health department so that sexual contacts within the past 60 days can be notified, tested, and treated presumptively with the dual drug regimen. Recommend simultaneous treatment for all current sex partners, and discourage sexual intercourse until symptoms have resolved. Promptly report any patient with suspected treatment failure to the local health department, and consult the local or state health department for recommendations on subsequent treatment regimens.

The US Preventive Services Task Force (USPSTF) recommends routine screening for asymptomatic infection in women at risk, as per the details in the TABLE.4 While the USPSTF found insufficient evidence to recommend screening of high-risk men, physicians might still consider screening men who have sex with multiple male partners.

TABLE
USPSTF recommendations on screening for gonorrhea
4

  • The USPSTF recommends that clinicians screen all sexually active women, including those who are pregnant, for gonorrhea infection if they are at increased risk for infection (that is, if they are young or have other individual or population risk factors).
    Rating: B recommendation.*
  • The USPSTF found insufficient evidence to recommend for or against routine screening for gonorrhea infection in men at increased risk for infection.
    Rating: I statement.
  • The USPSTF recommends against routine screening for gonorrhea infection in men and women who are at low risk for infection.
    Rating: D recommendation.
  • The USPSTF found insufficient evidence to recommend for or against routine screening for gonorrhea infection in pregnant women who are not at increased risk for infection.
    Rating: I statement.
USPSTF, US Preventive Services Task Force.
*For more on the USPSTF’s grade definitions, see: http://www.uspreventiveservicestaskforce.org/uspstf/gradespre.htm#brec.

Doing our best in the face of uncertainty
Although evidence is lacking that dual drug therapy will delay the progression of resistance, the strategy makes empirical sense. If gonorrhea develops resistance to cephalosporins, it will seriously challenge public health efforts to control this infection. Family physicians have an important role in controlling this sexually transmitted infection and helping to prevent drug resistance.

Pages

Recommended Reading

Going Green Can Turn Baby Bottoms Red
MDedge Family Medicine
Pediatric Rotavirus Immunization Curbs Adult Infections
MDedge Family Medicine
FDA Panel: Expand Approval of Pneumococcal Vaccine
MDedge Family Medicine
Physicians Are Paid Less for Combo Vaccine Administration
MDedge Family Medicine
New Tracking System Streamlines Inpatient Antibiotic Monitoring
MDedge Family Medicine
Acellular Pertussis Vaccine's Waning Immunity Caused California Epidemic
MDedge Family Medicine
Postimmunization Fever Boosts Sleep More Than Acetaminophen
MDedge Family Medicine
Treating Intestinal Bacteria May Improve Rosacea
MDedge Family Medicine
Large HIV Testing, Treatment Gaps Remain in U.S.
MDedge Family Medicine
Low-Dose IL-2 Induced HCV Vasculitis Remission
MDedge Family Medicine